Position in PCVX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$78,126
+$16,937 QoQ
Shares Held
1,344
+27.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#243
of 329 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO holds $32,462,816 across 144 Biotechnology names. PCVX ranks #25 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
53,309 | $6,043,108 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
48,894 | $5,993,426 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,613 | $4,775,065 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,101 | $3,180,677 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
10,526 | $2,536,450 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
35,863 | $2,052,080 | |
| 7 | RPRX |
Royalty Pharma plc
|
30,218 | $1,694,323 | |
| 8 | MRNA |
Moderna, Inc.
|
14,469 | $1,013,264 |
All Filings in PCVX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,126 | 1,344 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $61,189 | 1,053 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $22,839 | 495 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $14,083 | 391 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,582 | 264 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $16,992 | 450 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,420 | 54 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $7,656 | 67 | Shares | Defined | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||